Invention Grant
US08796241B2 Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase
有权
治疗甲基硫代腺苷磷酸化酶缺乏的肿瘤和感染因子
- Patent Title: Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase
- Patent Title (中): 治疗甲基硫代腺苷磷酸化酶缺乏的肿瘤和感染因子
-
Application No.: US12675276Application Date: 2008-08-15
-
Publication No.: US08796241B2Publication Date: 2014-08-05
- Inventor: Adam Lubin , Martin Lubin
- Applicant: Adam Lubin , Martin Lubin
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2008/009779 WO 20080815
- International Announcement: WO2009/032057 WO 20090312
- Main IPC: A61K31/7076
- IPC: A61K31/7076 ; A61K31/198 ; A61K31/519 ; A61K45/06
Abstract:
Methods for treating diseases in humans and vertebrate animals are provided using competitive antagonists of cellular metabolites combined with a protective agent for protecting host cells from toxic effects of the drugs. Also provided are kits comprising competitive antagonists and suitable protective agents. In addition, screening methods for identifying competitive antagonists, protective agents and potentiating agents, for use according to the methods of the invention, are provided.
Public/Granted literature
- US20120094947A1 METHOD FOR THE SELECTIVE THERAPY OF DISEASE Public/Granted day:2012-04-19
Information query
IPC分类:
